Sugi Predict

Sugi Predict / Compounds / SCHEMBL70281

SCHEMBL70281

SCHEMBL70281

O=C(O)c1cnn(-c2ccccc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH2 Q6NS38 2/20 1.00
▸ HPGDS O60760 1/20 1.00
▸ NPC1 O15118 4/20 0.64
▸ RAB9A P51151 4/20 0.64
▸ MAPT P10636 3/20 0.64
▸ HPGD P15428 2/20 0.64
▸ HTT P42858 2/20 0.64
▸ NFKB1 P19838 1/20 0.64
▸ NFKB2 Q00653 1/20 0.64
▸ RELA Q04206 1/20 0.64
▸ EGLN1 Q9GZT9 3/20 0.63
▸ KEAP1 Q14145 1/20 0.58
▸ NFE2L2 Q16236 1/20 0.58
▸ GAA P10253 1/20 0.58
▸ ALKBH1 Q13686 4/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ MEN1 O00255 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ POLB P06746 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7729542 0.89 HPGDS (0.79) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL27575419 0.87 ALKBH2 (0.77) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL27659040 0.86 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL27660233 0.85 ALKBH2 (0.73) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL4118702 0.85 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL2190049 0.85 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL19160308 0.85 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL18016128 0.85 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL29514702 0.85 ALKBH2 (0.74) ALKBH2HPGDSNPC1RAB9AMAPT
SCHEMBL29544594 0.84 ALKBH2 (0.73) ALKBH2HPGDSNPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2022-04-21 — — US claimed
CN-103649053-B Aminomethyl quinolone compounds 霍夫曼-拉罗奇有限公司 2017-07-04 — — CN claimed
EP-2731932-B1 AMINOMETHYL QUINOLONE COMPOUNDS HOFFMANN LA ROCHE (CH) 2015-12-30 — — EP claimed
EP-2731932-A1 AMINOMETHYL QUINOLONE COMPOUNDS F.HOFFMANN-LA ROCHE AG (CH) 2014-05-21 — — EP claimed
CN-103649053-A Aminomethyl quinolone compounds HOFFMANN LA ROCHE 2014-03-19 — — CN claimed
US-8501732-B2 Aminomethyl quinolone compounds HOFFMANN-LA ROCHE INC. (US) 2013-08-06 — — US claimed
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS BILOTTA JOSEPH A (US) 2013-01-17 — — US claimed
WO-2013007676-A1 AMINOMETHYL QUINOLONE COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2013-01-17 — — WO claimed
US-8129376-B2 Piperidine derivatives as inhibitors of stearoyl-CoA desaturase AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-03-06 — — US claimed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US claimed
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 — — US claimed
WO-2009117676-A2 NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-24 — — WO claimed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US claimed
CN-101511828-A Heteroaryl derivatives as protein kinase inhibitors HOFFMANN LA ROCHE (CH) 2009-08-19 — — CN claimed
EP-2064213-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2009-06-03 — — EP claimed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 — — WO claimed
WO-2008028617-A1 HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2008-03-13 — — WO claimed
EP-4737449-A1 P53-Y220C SELECTIVE SMALL-MOLECULAR REACTIVATOR COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF Changchun Genescience Pharmaceutical Co., Ltd. (CN) 2026-05-06 — — EP disclosed
US-5064851-A Enzyme inhibitors, antiinflammatory PFIZER INC. (US) 1991-11-12 — — US disclosed
US-4220792-A ANTIDIABETIC AGENTS SANDOZ, INC. (US) 1980-09-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS MAP3K1, MAP3K11, MAP3K5 ALKBH2 1985/4885HPGDS 624/4885NPC1 1624/4885
US-20090239810-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 ALKBH2 690/4885HPGDS 481/4885NPC1 201/4885
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 ALKBH2 750/4885HPGDS 482/4885NPC1 206/4885
US-20220119412-A1 THIAZOLOPYRIDINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS ADORA1, ADORA2A, ADORA3 ALKBH2 2155/4885HPGDS 567/4885NPC1 944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.